drugset / Trial / NCT00947791
Treatment Study of Bipolar Depression
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to determine whether a single intravenous administration of an N-methyl-D-aspartate antagonist is safe and effective for the acute treatment of bipolar depression.
Timeline
- Start
- 2009-07
- Primary completion
- 2009-10
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 0.5 mg/kg | Intravenous |
| Subject | Midazolam | Small molecule | 0.045 mg/kg | Intravenous |